All Stories

  1. Racing towards a digital paradise or a digital hell?
  2. A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial
  3. Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory
  4. Social cognition interventions for people with schizophrenia: a systematic review focussing on methodological quality and intervention modality
  5. National funding for mental health research in Finland, France, Spain and the United Kingdom
  6. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial
  7. Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients
  8. What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication
  9. Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis
  10. What proportion of patients with psychosis is willing to take part in research? A mental health electronic case register analysis
  11. Modeling the Interplay Between Psychological Processes and Adverse, Stressful Contexts and Experiences in Pathways to Psychosis: An Experience Sampling Study
  12. Improving Theory of Mind in Schizophrenia by Targeting Cognition and Metacognition with Computerized Cognitive Remediation: A Multiple Case Study
  13. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data
  14. Cognitive–behaviour therapy for post-traumatic stress in schizophrenia. A randomized controlled trial
  15. ECLIPSE Study 9: Implementation of Remediation into EI Services
  16. A Metacognitive Approach to Cognitive Remediation
  17. Psychosocial intervention in schizophrenia
  18. Substance Use Recovery Evaluator
  19. The Feasibility and Acceptability to Service Users of CIRCuiTS, a Computerized Cognitive Remediation Therapy Programme for Schizophrenia
  20. Cognitive Remediation in Schizophrenia
  21. E.01.02 ROAMER – collaborative effort to develop a mental health research roadmap: the results
  22. It is all in the factors: Effects of cognitive remediation on symptom dimensions
  23. Poster #M98 OPTIMISING THE DELIVERY OF COGNITIVE REMEDIATION FOR SCHIZOPHRENIA – RESULTS FROM A FEASIBILITY RANDOMISED CONTROLLED TRIAL OF A NEW COMPUTERISED PROGRAMME, CIRCUITS
  24. Does Change in Cognitive Function Predict Change in Costs of Care for People With a Schizophrenia Diagnosis Following Cognitive Remediation Therapy?
  25. Great expectations for participatory research: what have we achieved in the last ten years?
  26. Cognitive Therapies for Refractory Schizophrenia
  27. VOCALISE
  28. Identifying Cognitive Remediation Change Through Computational Modelling—Effects on Reinforcement Learning in Schizophrenia
  29. A trial of combining cognitive remediation and CBT for first episode psychosis
  30. Schizophrenia
  31. Schizophrenia
  32. Effects of Age and Cognitive Reserve on Cognitive Remediation Therapy Outcome in Patients With Schizophrenia
  33. Increased funding needed for mental health research
  34. Patient involvement in improving the evidence base on inpatient care: improving inpatient therapeutic environments
  35. The effectiveness of cognitive remediation therapy (CRT) for patients with schizophrenia
  36. Cognitive remediation for young people with schizophrenia
  37. Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication
  38. Patient involvement - inpatient care (WP3)
  39. Computerised Cognitive Remediation Therapy for Schizophrenia
  40. Patient involvement in improving the evidence base on inpatient care: changing service configuration - the "triage" model
  41. S.09.01 The role of contextual factors in predicting cognitive improvement
  42. Cognitive remediation therapy for young people with schizophrenia
  43. Depression and anxiety in schizophrenia
  44. Family interventions in schizophrenia
  45. Cognitive dysfunction in schizophrenia
  46. PSYCHOSOCIAL AND COMORBIDITIES
  47. Poster #148 COGNITIVE RESERVE: DOES IT MODIFY THE EFFECT OF AGE ON COGNITIVE REMEDIATION THERAPY OUTCOME IN SCHIZOPHRENIA?
  48. Effects of Age and Cognitive Reserve on Cognitive Remediation Therapy Outcome in Patients With Schizophrenia
  49. AS02-01 - Improving cognition and function - style trumps content
  50. Views of the Therapeutic Environment Measure
  51. CITRINE Tool
  52. Extending the clinical research network approach to all of healthcare
  53. Thinking About the Future Cognitive Remediation Therapy--What Works and Could We Do Better?
  54. Rapid progress or lengthy process? electronic personal health records in mental health
  55. Selecting outcome measures in mental health: the views of service users
  56. Erratum to “No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia” [Neurosci. Lett. 496 (2011) 65–69]
  57. A review of hearing voices groups: Evidence and mechanisms of change
  58. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: Developing Imaging Biomarkers to Enhance Treatment Development for Schizophrenia and Related Disorders
  59. No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia
  60. Tower of London versus Real Life Analogue Planning in Schizophrenia with Disorganization and Psychomotor Poverty Symptoms
  61. The Madrid Declaration: why we need a coordinated Europe-wide effort in mental health research
  62. Achieving Continuity of Care: Facilitators and Barriers in Community Mental Health Teams
  63. A Comparison of Participant Information Elicited by Service User and Non-Service User Researchers
  64. Revisiting Cognitive Remediation for Schizophrenia: Facing the Challenges of the Future
  65. Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study
  66. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial
  67. Cognitive remediation therapy needs funding
  68. Can we harness computerised cognitive bias modification to treat anxiety in schizophrenia? A first step highlighting the role of mental imagery
  69. Needs of homeless people for mental healthcare
  70. Review: cognitive impairment present in people with affective psychoses
  71. Diagnosis, diagnosis, diagnosis: towards DSM-5
  72. Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis
  73. Nurse and patient activities and interaction on psychiatric inpatients wards: A literature review
  74. Group Cognitive Behaviour Therapy for psychosis
  75. HOW EFFECTIVE IS CBTP AND DOES THIS DEPEND ON YOUR THERAPIST?
  76. IMPROVING OVERALL OUTCOMES - EXTENDING CBTP TO COMPLEX PROBLEMS
  77. WHAT FACTORS PREDICT AWARENESS OF COGNITIVE PROBLEMS IN PEOPLE WITH SCHIZOPHRENIA?
  78. Coercion and Treatment Satisfaction Among Involuntary Patients
  79. Imagery and Task-Feedback Questionnaire
  80. Ethnicity and coercion among involuntarily detained psychiatric in-patients
  81. Impaired verbal self-monitoring in individuals at high risk of psychosis
  82. Different Components of Metacognition and their Relationship to Psychotic-Like Experiences
  83. Evaluating integrated MI and CBT for people with psychosis and substance misuse: Recruitment, retention and sample characteristics of the MIDAS trial
  84. Does age matter? Effects of cognitive rehabilitation across the age span
  85. Illness careers and continuity of care in mental health services: A qualitative study of service users and carers
  86. The self or the voice? Relative contributions of self-esteem and voice appraisal in persistent auditory hallucinations
  87. Developing a user-generated measure of continuity of care: brief report
  88. Cognitive remediation for schizophrenia: it is even more complicated
  89. Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS Meeting
  90. Patients' views and readmissions 1 year after involuntary hospitalisation
  91. Group Cognitive Behavior Therapy or Social Skills Training for Individuals With a Recent Onset of Psychosis?
  92. Review: Cognitive remediation improves cognitive functioning in schizophrenia
  93. Executive functioning in schizophrenia and the relationship with symptom profile and chronicity
  94. Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative
  95. Letter to the Editor: Neuropsychological task performance before and after cognitive remediation in anorexia nervosa: a pilot case-series
  96. Continuity of care in mental health: understanding and measuring a complex phenomenon
  97. COGNITION REHABILITATION IN SCHIZOPHRENIA, II: COGNITION REHABILITATION, COSTS AND EFFECTIVENESS
  98. A PILOT STUDY OF A NEW COMPUTERISED COGNITIVE REMEDIATION PROGRAMME
  99. What Do Clients Think of Cognitive Remediation Therapy?: A Consumer-Led Investigation of Satisfaction and Side Effects
  100. Cognitive remediation and vocational rehabilitation.
  101. Mental health and perceptions of biomarker research – possible effects on participation
  102. What are mental health service users' priorities for research in the UK?
  103. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: An exploratory randomized controlled trial
  104. Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor
  105. Cognitive remediation therapy in schizophrenia
  106. Til Wykes
  107. Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop
  108. More than just a place to talk: Young people's experiences of group psychological therapy as an early intervention for auditory hallucinations
  109. WC12C GROUP CBT VS SKILLS TRAINING FOR FIRST EPISODES OF PSYCHOSIS – RESULTS OF A RCT
  110. Group Treatment of Perceived Stigma and Self-Esteem in Schizophrenia: A Waiting List Trial of Efficacy
  111. Schizophrenia Patients With Cognitive Deficits: Factors Associated With Costs
  112. Negative Symptoms and Specific Cognitive Impairments as Combined Targets for Improved Functional Outcome Within Cognitive Remediation Therapy
  113. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial
  114. Early Psychological Intervention for Auditory Hallucinations: An Exploratory Study of Young People??s Voices Groups
  115. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?
  116. Reshaping mental health practice with evidence: the Mental Health Research Network
  117. Psychological treatment for voices in psychosis
  118. Anger, psychopathology and cognitive inhibition: a study of UK servicemen
  119. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia
  120. Which cognitive skills should we target in cognitive remediation therapy?
  121. 'Next steps' on JMH - reform and consolidation
  122. IS IT TIME TO DEVELOP A NEW COGNITIVE THERAPY FOR PSYCHOSIS—COGNITIVE REMEDIATION THERAPY (CRT)?
  123. The Rehabilitation of Cognitive Deficits
  124. Cognitive impairment in early onset schizophrenia: associations with clinical symptoms
  125. What are we changing with neurocognitive rehabilitation?
  126. A randomised control trial of individual neurocognitive remediation: The effects on cognitive deficits & general functioning
  127. Aversive stimulation by staff and violence by psychiatric patients
  128. Response inhibition: A stable vulnerability factor in chronic schizophrenia
  129. Global Function Scales
  130. Predicting symptomatic and behavioural outcomes of community care
  131. Introduction
  132. Reactions to assault
  133. Violence and Health Care Professionals
  134. Counselling for victims of violence
  135. The prediction of violence in a health care setting
  136. Developments in clinical psychology
  137. Global function scales
  138. The assessment of severely disabled psychiatric patients for rehabilitation
  139. Violence and suicidality: Perspectives in clinical and psychobiological research
  140. Clinical treatment of the violent person
  141. Assessment schedules for chronic psychiatric patients
  142. A follow-up of ‘new’ long-stay patients in Camberwell, 1977–1982
  143. Disordered speech: Differences between manics and schizophrenics
  144. 4. Needs and the deployment of services
  145. 3. The role of relatives
  146. Inference and children's comprehension of pronouns
  147. Language and schizophrenia
  148. How do children learn the meanings of verbs?
  149. Cognitive Behaviour Therapy
  150. The toxicity of community care
  151. Cognitive Behaviour Therapy
  152. Antidepressant Medications in Clinical Practice